PLN 3.2
(-0.31%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 63.37 Thousand PLN | 36.36% |
2022 | 46.47 Thousand PLN | -3.87% |
2021 | 48.35 Thousand PLN | 21977172.66% |
2020 | 0.22 PLN | -99.95% |
2019 | 433.00 PLN | -96.14% |
2018 | 11.21 Thousand PLN | 239.82% |
2017 | 3300.00 PLN | 0.0% |
2016 | - PLN | 0.0% |
2015 | - PLN | 0.0% |
2014 | - PLN | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 8000.00 PLN | 0.0% |
2024 Q1 | 8000.00 PLN | -87.38% |
2023 Q2 | 251 Thousand PLN | 0.0% |
2023 Q4 | 63.37 Thousand PLN | 604.2% |
2023 Q1 | 251 Thousand PLN | 440.04% |
2023 Q3 | 9000.00 PLN | -96.41% |
2023 FY | 63.37 Thousand PLN | 36.36% |
2022 Q1 | 63.2 Thousand PLN | 30.73% |
2022 FY | 46.47 Thousand PLN | -3.87% |
2022 Q4 | 46.47 Thousand PLN | -24.23% |
2022 Q3 | 61.33 Thousand PLN | 0.0% |
2022 Q2 | 61.33 Thousand PLN | -2.96% |
2021 Q3 | 82.89 Thousand PLN | 131.69% |
2021 Q2 | 35.77 Thousand PLN | 0.0% |
2021 Q1 | - PLN | 100.0% |
2021 FY | 48.35 Thousand PLN | 21977172.66% |
2021 Q4 | 48.35 Thousand PLN | -41.67% |
2020 Q1 | 30.43 Thousand PLN | 6928.41% |
2020 Q4 | -758.69 Thousand PLN | -3484.44% |
2020 Q3 | 22.41 Thousand PLN | 5077.14% |
2020 FY | 0.22 PLN | -99.95% |
2020 Q2 | 433.00 PLN | -98.58% |
2019 Q3 | 11.21 Thousand PLN | 0.01% |
2019 Q1 | 11.21 Thousand PLN | 0.01% |
2019 FY | 433.00 PLN | -96.14% |
2019 Q4 | 433.00 PLN | -96.14% |
2019 Q2 | 11.21 Thousand PLN | -0.01% |
2018 Q1 | 10.8 Thousand PLN | 227.27% |
2018 Q4 | 11.21 Thousand PLN | -28.98% |
2018 Q2 | 1.00 PLN | -99.99% |
2018 Q3 | 15.79 Thousand PLN | 1578900.0% |
2018 FY | 11.21 Thousand PLN | 239.82% |
2017 Q4 | 3300.00 PLN | 0.0% |
2017 Q1 | - PLN | 0.0% |
2017 FY | 3300.00 PLN | 0.0% |
2017 Q3 | - PLN | 0.0% |
2016 FY | - PLN | 0.0% |
2015 FY | - PLN | 0.0% |
2014 FY | - PLN | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Bioceltix S.A. | 8617.89 PLN | -635.424% |
BIOTON S.A. | 117.91 Million PLN | 99.946% |
Captor Therapeutics Spolka Akcyjna | - PLN | -Infinity% |
Mabion S.A. | 6.84 Million PLN | 99.074% |
Molecure S.A. | - PLN | -Infinity% |
Pharmena S.A. | 445 Thousand PLN | 85.758% |
Poltreg S.A. | 415 Thousand PLN | 84.728% |
Pure Biologics Spólka Akcyjna | 17.56 Million PLN | 99.639% |
Ryvu Therapeutics S.A. | 2.11 Million PLN | 97.008% |
Synthaverse S.A. | 15.48 Million PLN | 99.591% |
Urteste S.A. | 162 Thousand PLN | 60.878% |